Telehealth ad compliance facts
The rules telehealth ads run into and recent enforcement against telehealth advertisers. Every item links to the regulator or platform page it came from, with the date we checked it.
These are the same 13 rules that power the free ad compliance checker. For each platform in plain English, see the Meta health ad policy, Google health ad policy and LegitScript pages.
Last updated · Download CSV
Enforcement against telehealth advertisers
FDA ·
FDA warned 30 telehealth companies against illegal marketing of compounded GLP-1s, citing claims that implied the drugs were the same as FDA-approved products and branding that hid who compounded them.
Source · checked 2026-10-30
FTC ·
The FTC approved the final order against NextMed. It bars misrepresenting that reviews are truthful or from real consumers and requires competent and reliable evidence for claims about typical results.
Source · checked 2026-10-30
FDA ·
FDA sent warning letters dated 9 September 2025 to telehealth companies over misleading claims about compounded GLP-1 drugs, including claims that products were FDA approved. FDA did not publish a single total; one example letter is linked.
Source · checked 2026-10-30
FTC ·
The FTC took action against telemedicine firm NextMed over charges it used misleading prices, fake reviews and deceptive weight loss claims to sell GLP-1 weight loss programs. The proposed order required a 150,000 USD payment.
Source · checked 2026-10-30
FTC ·
The FTC rule on the use of consumer reviews and testimonials took effect, allowing civil penalties for knowing violations such as fake testimonials.
Source · checked 2026-10-30
Platform and FTC rules
meta
META_RX_CERT
Ads promoting prescription drugs require active LegitScript certification (telehealth providers and online pharmacies) plus Meta authorization, and may only target eligible countries (US, Canada, New Zealand).
Source · checked 2026-10-29
META_TELEHEALTH_GENERAL
Ads that promote telehealth services generally, or educate about prescription drugs, do not need written authorization.
Source · checked 2026-10-29
META_RX_DISCLAIMER
Prescription drug ads must include a disclaimer to consult a licensed health professional or obtain a valid prescription.
Source · checked 2026-10-29
META_ONLINE_PHARMACY
Online pharmacies and telehealth providers promoting prescription drugs must be actively certified with LegitScript, then request authorization from Meta, and target only people 18 or older in eligible countries where they are certified.
Source · checked 2026-10-29
META_WEIGHT_18
Ads for dietary, health, weight loss or weight gain products and services, and for cosmetic products or procedures, must be targeted to people 18 or older.
Source · checked 2026-10-29
META_WEIGHT_BEFORE_AFTER
Meta's Health and Wellness policy (change log entry 22 July 2026) bans close-ups that pinch fat on a body area, claims that results come from wearables alone, and clickbait such as promises of specific outcomes within a set timeframe without disclaimers or qualifiers. FTC rules on typical results still apply.
Source · checked 2026-11-03
META_SELF_PERCEPTION
Weight loss, weight gain and cosmetic ads must not contain statements of inferiority about physical appearance: terms, descriptions or questions that are negative and attack an individual's appearance, body parts or hygiene.
Source · checked 2026-10-29
META_REPRO_HEALTH
Sexual and reproductive health ads must target 18+ and focus on health and medical efficacy, not sexual pleasure or enhancement. Prescription products also follow the Drugs and Pharmaceuticals policy.
Source · checked 2026-10-29
META_PERSONAL_ATTRIBUTES
Ads must not assert or imply personal attributes of the viewer, including medical conditions, mental health, age or financial status. 'You' is allowed when it does not reference a personal attribute.
Source · checked 2026-10-29
GOOGLE_TELEMED_CERT
In the United States, Google allows telemedicine providers accredited by LegitScript's Healthcare Merchant Certification Program, and online pharmacies accredited by LegitScript or NABP. Advertisers must also be certified with Google. Rules differ by country.
Source · checked 2026-11-02
ftc
FTC_SUBSTANTIATION
Health benefit or safety claims need competent and reliable scientific evidence, generally randomized controlled human clinical testing. Testimonials and expert endorsements do not replace substantiation.
Source · checked 2026-10-29
FTC_TYPICAL_RESULTS
Testimonials showing results that are not typical are likely deceptive, and 'results not typical' does not fix that. Ads should clearly disclose the results a typical consumer can expect.
Source · checked 2026-10-29
fda/ftc
COMPOUNDED_EQUIVALENCE
Compounded drugs are not FDA approved: FDA does not review their safety, effectiveness or quality before they are marketed. Claims that a compounded product is FDA approved, generic, or the same as a branded drug are high risk.
Source · checked 2026-10-29
What the compliance checker flags most
Coming soon. Once the free checker has run enough times, this section will show which rule types get flagged most by vertical, counted from anonymous run logs. Nothing is shown until then.
How to cite this page
Telehealth Media, "Telehealth ad compliance facts", https://telehealthmedia.com/data/telehealth-ad-compliance-statistics, updated 2026-10-30.
Please link to this page when you use the data.
Creative by vertical
Changelog
- : First version: platform rules from the compliance checker rule set, FTC NextMed action, FDA warning letters to telehealth companies.